TEPEZZA

TEPEZZA (teprotumumab-trbw) is an insulin-like growth factor-1 receptor inhibitor used to treat Thyroid Eye Disease, an autoimmune disease characterized by proptosis (a condition where the eyes are pushed forward and bulge outward) leading to eye pain, double vision, and difficulty closing the eyelid.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

TEPEZZA REFERRAL FORM

What it treats

Thyroid Eye Disease (TED)

Prescribed by

Ophthalmologists

How it’s administered

Intravenous (IV) infusion

Frequency

Once every three weeks for eight doses

Length of treatment

About 90 minutes